BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12061776)

  • 1. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters.
    Maeda T; Gupta MP; Stewart AF
    Biochem Biophys Res Commun; 2002 Jun; 294(4):791-7. PubMed ID: 12061776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57.
    Kobarg CB; Kobarg J; Crosara-Alberto DP; Theizen TH; Franchini KG
    FEBS Lett; 2005 May; 579(12):2615-22. PubMed ID: 15862299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Xenopus MyoD transcription by members of the MEF2 protein family.
    Wong MW; Pisegna M; Lu MF; Leibham D; Perry M
    Dev Biol; 1994 Dec; 166(2):683-95. PubMed ID: 7813786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor-1.
    Gupta M; Kogut P; Davis FJ; Belaguli NS; Schwartz RJ; Gupta MP
    J Biol Chem; 2001 Mar; 276(13):10413-22. PubMed ID: 11136726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel functional co-operation between MyoD, MEF2 and TRalpha1 is sufficient for the induction of GLUT4 gene transcription.
    Santalucía T; Moreno H; Palacín M; Yacoub MH; Brand NJ; Zorzano A
    J Mol Biol; 2001 Nov; 314(2):195-204. PubMed ID: 11718554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR.
    Creemers EE; Sutherland LB; Oh J; Barbosa AC; Olson EN
    Mol Cell; 2006 Jul; 23(1):83-96. PubMed ID: 16818234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of MEF2A core bound to DNA at 1.5 A resolution.
    Santelli E; Richmond TJ
    J Mol Biol; 2000 Mar; 297(2):437-49. PubMed ID: 10715212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
    Zang MX; Li Y; Xue LX; Jia HT; Jing H
    J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations within the conserved MADS box of the D-MEF2 muscle differentiation factor result in a loss of DNA binding ability and lethality in Drosophila.
    Nguyen T; Wang J; Schulz RA
    Differentiation; 2002 Oct; 70(8):438-46. PubMed ID: 12366381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation and evolution in and among SRF- and MEF2-type MADS domains and their binding sites.
    Wu W; Huang X; Cheng J; Li Z; de Folter S; Huang Z; Jiang X; Pang H; Tao S
    Mol Biol Evol; 2011 Jan; 28(1):501-11. PubMed ID: 20724380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innervation-dependent and fiber type-specific transcriptional regulation of the slow myosin heavy chain 2 promoter in avian skeletal muscle fibers.
    Jiang H; Jordan T; Li J; Li H; DiMario JX
    Dev Dyn; 2004 Oct; 231(2):292-302. PubMed ID: 15366006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VITO-1 is an essential cofactor of TEF1-dependent muscle-specific gene regulation.
    Günther S; Mielcarek M; Krüger M; Braun T
    Nucleic Acids Res; 2004; 32(2):791-802. PubMed ID: 14762206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mef2 proteins, required for muscle differentiation, bind an essential site in the Ig lambda enhancer.
    Satyaraj E; Storb U
    J Immunol; 1998 Nov; 161(9):4795-802. PubMed ID: 9794411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional analysis of domains mediating interaction between the bagpipe homologue, Nkx3.1 and serum response factor.
    Zhang Y; Fillmore RA; Zimmer WE
    Exp Biol Med (Maywood); 2008 Mar; 233(3):297-309. PubMed ID: 18296735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D.
    Slepak TI; Webster KA; Zang J; Prentice H; O'Dowd A; Hicks MN; Bishopric NH
    J Biol Chem; 2001 Mar; 276(10):7575-85. PubMed ID: 11096067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor.
    De Luca A; Severino A; De Paolis P; Cottone G; De Luca L; De Falco M; Porcellini A; Volpe M; Condorelli G
    Biochem J; 2003 Feb; 369(Pt 3):477-84. PubMed ID: 12371907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA-dependent recruitment of MEF2 proteins to target promoters.
    Morin S; Charron F; Robitaille L; Nemer M
    EMBO J; 2000 May; 19(9):2046-55. PubMed ID: 10790371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
    Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
    Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription enhancer factor 1 binds multiple muscle MEF2 and A/T-rich elements during fast-to-slow skeletal muscle fiber type transitions.
    Karasseva N; Tsika G; Ji J; Zhang A; Mao X; Tsika R
    Mol Cell Biol; 2003 Aug; 23(15):5143-64. PubMed ID: 12861002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.
    Lu J; McKinsey TA; Nicol RL; Olson EN
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4070-5. PubMed ID: 10737771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.